Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1999 Apr;9(2):393-413.
doi: 10.1111/j.1750-3639.1999.tb00234.x.

Neurotrophic factors in peripheral neuropathies: therapeutic implications

Affiliations
Review

Neurotrophic factors in peripheral neuropathies: therapeutic implications

S C Apfel. Brain Pathol. 1999 Apr.

Abstract

Neurotrophic factors are proteins which promote the survival of specific neuronal populations. Many have other physiological effects on neurons such as inducing morphological differentiation, enhancing nerve regeneration, stimulating neurotransmitter expression, and otherwise altering the physiological characteristics of neurons. These properties suggest that neurotrophic factors are highly promising as potential therapeutic agents for neurological disease. Neurotrophic factors will most likely be applied to the peripheral nervous system initially, since there are fewer problems for large proteins to gain access to peripheral neurons. Many of the most intensively studied factors are active in the peripheral nervous system. These include the neurotrophins (nerve growth factor, brain derived neurotrophic factor, neurotrophin-3, neurotrophin-4/5), the insulin like growth factors, ciliary neurotrophic factor, and glial cell derived neurotrophic factor and its related proteins. The biology of these factors and their receptors in the peripheral nervous system is reviewed here. We also review data suggesting that abnormal availability of some factors may contribute towards the pathogenesis of certain types of peripheral neuropathy. Finally, the pre-clinical data suggesting that individual factors might be effective in treating neuropathy is reviewed, along with data relating to possible side effects of neurotrophic factor therapy. Several factors have already entered clinical trials with variable success. The data from these trials is reviewed as well.

PubMed Disclaimer

References

    1. Acheson A, Conover JC, Fandl JP, DeChiara TM, Russell M, Thadani A, Squinto SP, Yancopoulos GD, Lindsay RM (1995) A BDNF autocrine loop in adult sensory neurons prevents cell death. Nature 374: 450–453. - PubMed
    1. Aebischer P, Schluep M, Deglon N, Joseph J‐M, Hirt L, Heyd B, Goddard M, Hammang JP, Zurn AD, Kato AC, Regli F, Baetge EE (1996) Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients. 2: 696–699. - PubMed
    1. Anand P, Rudge P, Mathias CJ, Springall DR, Ghatei MA, Naher‐Noe M, Sharief M, Misra VP, Polak JM, Bloom SR, Thomas PK (1991) New autonomic and sensory neuropathy with loss of adrenergic sympathetic function and sensory neuropeptides. Lancet 337: 1253–1254. - PubMed
    1. Anand P, Terenghi G, Warner G, Kopelman P, Williams‐Chestnut RE, Sinicropi DV (1996) The role of endogenous nerve growth factor in human diabetic neuropathy. Nature Medicine 2: 703–707. - PubMed
    1. Ang LC, Bhaumick B, Munoz DG, Sass J, Juurlink BHJ (1992) Effects of astrocytes, insulin, and insulin like growth factor‐I on the survival of motor neurons in vitro. J Neurol Sci 109: 168–172. - PubMed

MeSH terms